OCT vs fundus photography: which catches what

At a modern eye exam you may have two very different pictures taken of the back of your eye: a fundus photograph — a flat colour photo of the retinal surface — and an OCT scan — a cross-section that looks like a slice through the retina's layers. Patients often assume they are two versions of the same thing. They are not. They answer different questions, catch different problems, and miss different things. This post is a patient's map of what each one does, plus the honest note that both are structural images — and structure is not the same as function.

TL;DR. Fundus photography is a colour photo of the retinal surface — great for documenting what can be seen looking in: haemorrhages, drusen, the optic disc, diabetic changes. OCT (optical coherence tomography) is a cross-sectional scan of the retinal layers at near-microscopic resolution (Huang et al., 1991) — it reveals fluid, swelling, layer thinning, and structural detail a surface photo cannot. They are complementary, not interchangeable. And both are structural: they image tissue, not how well you see. Functional measures like the visual field and contrast sensitivity can register change before — or independently of — what an image shows.

Fundus photography: the surface view

A fundus camera takes a wide, flat, colour photograph of the retina as seen through the pupil — the same view your ophthalmologist gets looking in with a lens, but captured and stored. It is excellent at documenting the appearance of the retinal surface and the structures on it:

• The optic disc — its colour, margins, and cup, relevant to glaucoma and neurological conditions.
• Diabetic changes — microaneurysms, dot-and-blot haemorrhages, cotton-wool spots, new vessels.
• Drusen and pigment changes of age-related macular degeneration.
• Haemorrhages, emboli, and vascular changes that can reflect systemic disease.

Its strengths are breadth, speed, and documentation: a single photo covers a large area, is easy to compare across visits, and increasingly can be captured without dilation and even screened by software. Its limitation is that it is two-dimensional and surface-oriented. It shows what a change looks like from the front, but it cannot see into the tissue. Swelling within the retina, fluid under it, or thinning of a specific layer can be invisible or ambiguous on a flat photo.

OCT: the cross-section

Optical coherence tomography does something a camera cannot. Introduced by Huang and colleagues in 1991, it uses the interference of reflected light — an optical analogue of ultrasound — to build a cross-sectional image of the retina at a resolution of a few microns, fine enough to resolve its individual layers (Huang et al., 1991). Where a fundus photo is a view of the surface, an OCT is a slice through it.

That cross-section is the workhorse of modern retinal medicine because it reveals things structure-in-depth hides:

• Fluid and swelling — diabetic macular edema, or fluid from wet AMD — often before it is obvious on a surface photo. This is arguably OCT's single most important contribution: it detects the treatable, sight-threatening fluid that guides injection therapy.
• Retinal layer thinning — including the retinal nerve fibre layer and ganglion cell complex, which thin in glaucoma. OCT can quantify this thinning, sometimes before a visual field defect appears.
• The macular architecture — the precise contours and layers of the central retina, for staging AMD, macular holes, membranes, and more.

OCT's limitations are the mirror image of the fundus camera's: it images a narrow slice or region in exquisite depth rather than a wide area at the surface, and interpreting it takes training. The two are designed to be used together — the photo for the lay of the land, the OCT for what is happening inside the ground.

A quick map of which tool catches what

The pattern: fundus photography surveys the surface broadly; OCT sections the tissue deeply. Neither replaces the other, and a comprehensive exam often uses both plus a dilated view by the clinician's own eye.

The catch: both are structure, not function

Here is the thread that connects this to everything else we write. Both OCT and fundus photography are structural — they image the tissue. Neither measures how well the tissue works. And in several eye conditions, function and structure come apart.

In glaucoma, a meaningful fraction of retinal ganglion cells can be lost before a reliable defect appears on standard visual field testing (Kerrigan-Baumrind et al., 2000) — structure and function each lead the other in different patients. In AMD, functional measures can flag trouble early: Owsley and colleagues showed that delayed rod-mediated dark adaptation — a functional test, not an image — predicts incident early AMD in people whose maculas still look healthy (Owsley et al., 2016). And contrast sensitivity is reduced early in AMD, glaucoma, and diabetes while high-contrast acuity and sometimes the images still look fine.

The point is not that imaging is unreliable — it is superb, and it detects things no functional test can. The point is that an image and a function test answer different questions, and a complete picture uses both. "Your OCT looks good" is genuinely reassuring about retinal structure. It is not the same statement as "your vision works perfectly," because the eye can lose function the picture does not yet show, and can keep function the picture makes look worse than it is. Our post on why one test isn't enough develops this from the tracking angle.

What this does and does not mean

Note. OCT and fundus photography are clinical imaging tools performed and interpreted by eye-care professionals. This post explains what they show; it does not interpret your scans.

A contrast sensitivity test — from us or anyone — is a functional screening signal. It does not image the retina, does not detect fluid or layer thinning, and does not replace OCT, fundus photography, or a dilated exam. It measures a different thing: how faint a pattern you can see.

A normal image does not guarantee normal function, and reduced function does not always mean a visible structural change. Both belong in the same conversation with your eye doctor. Any sudden vision change deserves prompt clinical attention regardless of past imaging.

Frequently asked questions

What is the difference between OCT and a fundus photo?

A fundus photograph is a flat colour photo of the retinal surface — good for documenting haemorrhages, drusen, the optic disc, and diabetic changes over a wide area. An OCT is a cross-sectional scan of the retinal layers at near-microscopic resolution, good for detecting fluid, swelling, and layer thinning that a surface photo cannot show. They are complementary: broad surface survey versus deep tissue slice.

Which is better, OCT or fundus photography?

Neither is "better" — they answer different questions. For detecting macular fluid (diabetic edema, wet AMD) or measuring nerve-fibre-layer thinning in glaucoma, OCT is essential. For a broad survey of the retinal surface and documenting its appearance over time, fundus photography excels. A thorough exam frequently uses both.

Does a normal OCT mean my vision is fine?

Not exactly. OCT images retinal structure; it does not measure visual function. Vision can be affected while structure still looks normal, and structure can look abnormal while function holds up. A normal OCT is reassuring about the tissue but is not the same as a full functional check, which is why visual field testing and measures like contrast sensitivity exist.

Can OCT detect glaucoma before symptoms?

OCT can measure thinning of the retinal nerve fibre layer and ganglion cell complex, sometimes before a visual field defect is detectable — a genuinely valuable early signal. But glaucoma is diagnosed from the whole picture (pressure, optic-nerve appearance, visual field, and OCT together), and a meaningful share of ganglion cells can be lost before functional tests register it (Kerrigan-Baumrind et al., 2000). Structure and function are both needed.

Can a home contrast test replace retinal imaging?

No. A contrast sensitivity test measures one aspect of visual function and cannot see the retina at all. It is a between-visit screening signal that can prompt or inform a clinical exam — never a substitute for OCT, fundus photography, or a dilated examination.

Take the test

Imaging shows your eye doctor the structure of your retina. A contrast sensitivity test measures one thing the images cannot: how your visual system actually performs at low contrast.

Take the test now. It is free, runs in your browser in about three minutes, and gives you a functional baseline to track over time and bring to your next exam. See the methodology page for the calibration details. A screening signal alongside your clinical imaging — never a replacement for it.

References

• Huang, D., Swanson, E. A., Lin, C. P., Schuman, J. S., Stinson, W. G., Chang, W., Hee, M. R., Flotte, T., Gregory, K., Puliafito, C. A., & Fujimoto, J. G. (1991). Optical coherence tomography. Science, 254(5035), 1178–1181. The original paper introducing OCT — cross-sectional imaging of tissue at micron-scale resolution, now the workhorse of retinal medicine.
• Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D. F., & Mitra, R. S. (2000). Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative Ophthalmology & Visual Science, 41(3), 741–748. Source for the finding that many retinal ganglion cells can be lost before a corresponding visual field defect is reliably detectable — the structure/function gap.
• Owsley, C., McGwin, G., Jr., Clark, M. E., Jackson, G. R., Callahan, M. A., Kline, L. B., Witherspoon, C. D., & Curcio, C. A. (2016). Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration. Ophthalmology, 123(2), 344–351. Showed a functional test predicting AMD onset in eyes that still looked structurally healthy — evidence that function can lead imaging.
• Pelli, D. G., Robson, J. G., & Wilkins, A. J. (1988). The design of a new letter chart for measuring contrast sensitivity. Clinical Vision Sciences, 2, 187–199. The Pelli-Robson chart — the clinical instrument for the functional contrast measurement that complements structural imaging.